{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:00:20Z","timestamp":1794895220016,"version":"4.9.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004286","name":"Santen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004286","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005188","name":"Tobacco-Related Disease Research Program","doi-asserted-by":"publisher","award":["T31IP1511"],"award-info":[{"award-number":["T31IP1511"]}],"id":[{"id":"10.13039\/100005188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007816","name":"Alcon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007816","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY022589"],"award-info":[{"award-number":["P30EY022589"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY011008"],"award-info":[{"award-number":["R01EY011008"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY019869"],"award-info":[{"award-number":["R01EY019869"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY026574"],"award-info":[{"award-number":["R01EY026574"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY027510"],"award-info":[{"award-number":["R01EY027510"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY029058"],"award-info":[{"award-number":["R01EY029058"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["U10EY014267"],"award-info":[{"award-number":["U10EY014267"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ajo.2021.11.018","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T08:43:43Z","timestamp":1637311423000},"page":"193-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Multilayer Macula Vessel Density and Visual Field Progression in Glaucoma"],"prefix":"10.1016","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2916-9187","authenticated-orcid":false,"given":"ALIREZA","family":"KAMALIPOUR","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SASAN","family":"MOGHIMI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0082-8353","authenticated-orcid":false,"given":"HUIYUAN","family":"HOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAMES A.","family":"PROUDFOOT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8312-6623","authenticated-orcid":false,"given":"TAKASHI","family":"NISHIDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1143-5224","authenticated-orcid":false,"given":"LINDA M.","family":"ZANGWILL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-3202","authenticated-orcid":false,"given":"ROBERT N.","family":"WEINREB","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2021.11.018_bib0001","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2021.11.018_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.67","article-title":"Primary open-angle glaucoma","volume":"2","author":"Weinreb","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ajo.2021.11.018_bib0003","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.10.001","article-title":"Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma","volume":"56","author":"De Moraes","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2021.11.018_bib0004","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ajo.2018.12.007","article-title":"Parapapillary deep-layer microvasculature dropout and visual field progression in glaucoma","volume":"200","author":"Kwon","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0005","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0006","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","article-title":"Predictors of long-term progression in the early manifest glaucoma trial","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0007","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration","volume":"130","author":"Ophthalmol","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0008","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajo.2007.04.040","article-title":"Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study","volume":"144","author":"Miglior","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0009","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0002-9394(03)00484-7","article-title":"Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy","volume":"136","author":"Medeiros","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0002-9394(01)00964-3","article-title":"Risk factors for progression of visual field abnormalities in normal-tension glaucoma","volume":"131","author":"Drance","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0011","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ophtha.2007.03.017","article-title":"Risk factors for incident open-angle glaucoma: the Barbados Eye Studies","volume":"115","author":"Leske","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0012","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.ophtha.2006.06.022","article-title":"Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study","volume":"113","author":"Budenz","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0013","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2008.05.031","article-title":"Ophthalmology EgJ. Disc hemorrhages and treatment in the early manifest glaucoma trial","volume":"115","author":"Bengtsson","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0014","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ajo.2021.05.026","article-title":"Characteristics of central visual field progression in eyes with optic disc hemorrhage","volume":"231","author":"David","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0015","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.ophtha.2014.02.017","article-title":"Effect of focal lamina cribrosa defect on glaucomatous visual field progression","volume":"121","author":"Faridi","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0016","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1167\/iovs.03-1274","article-title":"Predictive factors of the optic nerve head for development or progression of glaucomatous visual field loss","volume":"45","author":"Jonas","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.11.018_bib0017","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.ophtha.2011.06.014","article-title":"The region of largest \u03b2-zone parapapillary atrophy area predicts the location of most rapid visual field progression","volume":"118","author":"Teng","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0018","series-title":"Ocular blood flow in glaucoma","author":"Weinreb","year":"2009"},{"key":"10.1016\/j.ajo.2021.11.018_bib0019","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","article-title":"The impact of ocular blood flow in glaucoma","volume":"21","author":"Flammer","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2021.11.018_bib0020","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/bjo.2006.093633","article-title":"Glaucoma progression is associated with decreased blood flow velocities in the short posterior ciliary artery","volume":"90","author":"Zeitz","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0021","first-page":"305","article-title":"Baseline retrobulbar blood flow is associated with both functional and structural glaucomatous progression after 4 years","volume":"101","author":"Moore","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0022","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.exer.2010.09.002","article-title":"The complex interaction between ocular perfusion pressure and ocular blood flow - relevance for glaucoma","volume":"93","author":"Schmidl","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2021.11.018_bib0023","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s00417-005-0227-9","article-title":"Asymmetric visual field loss and retrobulbar haemodynamics in primary open-angle glaucoma","volume":"244","author":"Plange","year":"2006","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0024","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/bjo.2006.093633","article-title":"Glaucoma progression is associated with decreased blood flow velocities in the short posterior ciliary artery","volume":"90","author":"Zeitz","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/158097","article-title":"Retrobulbar hemodynamics and visual field progression in normal tension glaucoma: a long-term follow-up study","volume":"2015","author":"Kuerten","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.ajo.2021.11.018_bib0026","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1600-0420.2005.00567.x","article-title":"Predictive value of colour Doppler imaging in a prospective study of visual field progression in primary open-angle glaucoma","volume":"83","author":"Mart\u00ednez","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ajo.2021.11.018_bib0027","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000310526","article-title":"Possible correlations of ocular blood flow parameters with intraocular pressure and visual-field alterations in glaucoma: a study by means of color Doppler imaging","volume":"208","author":"Galassi","year":"1994","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ajo.2021.11.018_bib0028","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1167\/iovs.19-27230","article-title":"Sectoral differences in the association of optic nerve head blood flow and glaucomatous visual field defect severity and progression","volume":"60","author":"Kiyota","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.11.018_bib0029","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/17434440.2016.1230014","article-title":"Optical coherence tomography angiography and glaucoma: searching for the missing link","volume":"13","author":"KJEromd","year":"2016","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.ajo.2021.11.018_bib0030","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1364\/OE.20.004710","article-title":"Split-spectrum amplitude-decorrelation angiography with optical coherence tomography","volume":"20","author":"Jia","year":"2012","journal-title":"Opt Express"},{"key":"10.1016\/j.ajo.2021.11.018_bib0031","doi-asserted-by":"crossref","first-page":"OCT451","DOI":"10.1167\/iovs.15-18944","article-title":"Optical coherence tomography angiography vessel density in healthy, glaucoma suspect, and glaucoma eyes","volume":"57","author":"Yarmohammadi","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.11.018_bib0032","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.ophtha.2016.08.041","article-title":"Relationship between optical coherence tomography angiography vessel density and severity of visual field loss in glaucoma","volume":"123","author":"Yarmohammadi","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0033","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.ophtha.2018.05.006","article-title":"Macular and optic nerve head vessel density and progressive retinal nerve fiber layer loss in glaucoma","volume":"125","author":"Moghimi","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0034","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajo.2021.01.015","article-title":"Association between progressive retinal capillary density loss and visual field progression in open-angle glaucoma patients according to disease stage","volume":"226","author":"Shin","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0035","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ophtha.2019.12.030","article-title":"Ganglion cell complex thickness and macular vessel density loss in primary open-angle glaucoma","volume":"127","author":"Hou","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0036","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.ophtha.2020.12.027","article-title":"OCT Angiography for the diagnosis of glaucoma: a report by the American Academy of Ophthalmology","volume":"128","author":"WuDunn","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0037","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.ophtha.2014.01.021","article-title":"Optical coherence tomography angiography of optic disc perfusion in glaucoma","volume":"121","author":"Jia","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0038","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/IJG.0000000000000964","article-title":"Optical coherence tomography angiography macular vascular density measurements and the central 10-2 visual field in glaucoma","volume":"27","author":"Penteado","year":"2018","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2021.11.018_bib0039","article-title":"Macular thickness and microvasculature loss in glaucoma suspect eyes","author":"Hou","year":"2021","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ajo.2021.11.018_bib0040","article-title":"Measurements of OCTA complement OCT for diagnosing early primary open angle glaucoma","author":"Kamalipour","year":"2021","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ajo.2021.11.018_bib0041","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ophtha.2017.10.029","article-title":"Peripapillary and macular vessel density in patients with primary open-angle glaucoma and unilateral visual field loss","volume":"125","author":"Yarmohammadi","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0042","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ophtha.2017.01.004","article-title":"Peripapillary and macular vessel density in patients with glaucoma and single-hemifield visual field defect","volume":"124","author":"Yarmohammadi","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0043","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1167\/iovs.61.14.33","article-title":"Focal structure-function relationships in primary open-angle glaucoma using OCT and OCT-A measurements","volume":"61","author":"Wong","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.11.018_bib0044","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00417-017-3865-9","article-title":"Correlation of flow density, as measured using optical coherence tomography angiography, with structural and functional parameters in glaucoma patients","volume":"256","author":"Alnawaiseh","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0045","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00417-017-3671-4","article-title":"Optical coherence tomography angiography vessel density mapping at various retinal layers in healthy and normal tension glaucoma eyes","volume":"255","author":"Shin","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0046","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00417-018-3965-1","article-title":"OCTA vessel density changes in the macular zone in glaucomatous eyes","volume":"256","author":"Lommatzsch","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0047","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1097\/IJG.0000000000001860","article-title":"Superficial and deep macula vessel density in healthy, glaucoma suspect, and glaucoma eyes","volume":"30","author":"El-Nimri","year":"2021","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2021.11.018_bib0048","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.ophtha.2017.06.002","article-title":"Projection-resolved optical coherence tomography angiography of macular retinal circulation in glaucoma","volume":"124","author":"Takusagawa","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0049","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/jamaophthalmol.2019.1212","article-title":"Evaluation of parapapillary choroidal microvasculature dropout and progressive retinal nerve fiber layer thinning in patients with glaucoma","volume":"137","author":"Kim","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0050","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archophthalmol.2009.187","article-title":"The African descent and glaucoma evaluation study (ADAGES): design and baseline data","volume":"127","author":"Sample","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0051","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.8.5.2","article-title":"Comparison of methods to detect and measure glaucomatous visual field progression","volume":"8","author":"Rabiolo","year":"2019","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0052","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ophtha.2013.10.018","article-title":"Defining 10-2 visual field progression criteria: exploratory and confirmatory factor analysis using pointwise linear regression","volume":"121","author":"de Moraes","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0053","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1167\/iovs.05-0827","article-title":"Visual Field progression in glaucoma: total versus pattern deviation analyses","volume":"46","author":"Artes","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.11.018_bib0054","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ophtha.2019.01.029","article-title":"Agreement and predictors of discordance of 6 visual field progression algorithms","volume":"126","author":"Saeedi","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archopht.123.2.193","article-title":"Pointwise linear regression for evaluation of visual field outcomes and comparison with the Advanced Glaucoma Intervention Study methods","volume":"123","author":"Nouri-Mahdavi","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0056","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1167\/iovs.13-11680","article-title":"Refinement of pointwise linear regression criteria for determining glaucoma progression","volume":"54","author":"Kummet","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.11.018_bib0057","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.ophtha.2021.03.036","article-title":"OCT angiography artifacts in glaucoma","volume":"128","author":"Kamalipour","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0058","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajo.2016.09.015","article-title":"Baseline Fourier-domain optical coherence tomography structural risk factors for visual field progression in the Advanced Imaging for Glaucoma Study","volume":"172","author":"Zhang","year":"2016","journal-title":"Am J Ophthtalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0059","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random-effects models for longitudinal data","volume":"38","author":"Laird","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.ajo.2021.11.018_bib0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/096228029200100302","article-title":"Longitudinal studies with continuous responses","volume":"1","author":"Laird","year":"1992","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.ajo.2021.11.018_bib0061","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0062","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ophtha.2006.07.060","article-title":"Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial","volume":"114","author":"Bengtsson","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0063","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","article-title":"Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery","volume":"108","author":"Lichter","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.018_bib0064","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajo.2016.09.015","article-title":"Baseline Fourier-domain optical coherence tomography structural risk factors for visual field progression in the advanced imaging for glaucoma study","volume":"172","author":"Zhang","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0065","doi-asserted-by":"crossref","first-page":"16813","DOI":"10.1038\/s41598-019-53354-4","article-title":"Association of retinal blood flow with progression of visual field in glaucoma","volume":"9","author":"Jeon","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2021.11.018_bib0066","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/jamaophthalmol.2018.1746","article-title":"Association between 24-hour intraocular pressure monitored with contact lens sensor and visual field progression in older adults with glaucoma","volume":"136","author":"De Moraes","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0067","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/archophthalmol.2009.297","article-title":"Prediction of glaucomatous visual field loss by extrapolation of linear trends","volume":"127","author":"Bengtsson","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0068","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jamaophthalmol.2017.3431","article-title":"Repeatability and reproducibility of superficial macular retinal vessel density measurements using optical coherence tomography angiography en face images","volume":"135","author":"Lei","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.018_bib0069","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/jamaophthalmol.2019.0467","article-title":"Promise of optical coherence tomography angiography in determining progression of glaucoma","volume":"137","author":"Yousefi","year":"2019","journal-title":"JAMA Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421006000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421006000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:49:25Z","timestamp":1757598565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939421006000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":69,"alternative-id":["S0002939421006000"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2021.11.018","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multilayer Macula Vessel Density and Visual Field Progression in Glaucoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2021.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}